Health

A recent study has shed light on the missed opportunities in treating drug overdose survivors under the Medicare program. It highlighted the challenges of managing chronic pain in this vulnerable population. Despite recommendations from experts to prioritize comprehensive treatment for overdose survivors, the reality is quite different. The study found that a significant number of
0 Comments
The approval of PD-1-directed immune checkpoint inhibitor pembrolizumab in combination with carboplatin and paclitaxel is a significant advancement for patients with primary advanced or recurrent endometrial cancer. The results of the KEYNOTE-868/NRG-GY018 trial showed that patients with either mismatch repair (MMR)-deficient or MMR-proficient disease benefited from this immunotherapy-chemotherapy combination. In the trial, the addition of
0 Comments
Dean Ornish, MD, believes that an intensive lifestyle intervention could potentially slow down the progression of early Alzheimer’s disease. This is a groundbreaking approach that challenges traditional methods of treatment for the condition. However, while the idea of “good” side effects is promising, it is important to approach such interventions with caution and further research
0 Comments
In a recent study presented at the European Alliance of Associations for Rheumatology (EULAR) annual meeting, the efficacy of patient-initiated follow-up contacts versus clinician-monitored follow-up for patients with axial spondyloarthritis (axSpA) was examined. This study, conducted by Inger Jorid Berg, MD, PhD, emphasized the potential benefits of letting patients take the lead in managing their
0 Comments
Air pollution is a growing concern not only for the environment but also for human health, especially for pregnant women. Recent studies have brought to light the troubling connection between maternal exposure to particulate matter (PM) and adverse outcomes during pregnancy, particularly relating to blood pressure issues. It is crucial to address this hidden risk
0 Comments
The advancement in research for the treatment of EGFR-mutant non-small cell lung cancer is crucial in improving patient outcomes. In a recent study conducted by Erminia Massarelli, MD, PhD, the combination of osimertinib and consolidative stereotactic ablative radiation (SABR) showed promising results. The study involved 43 patients with untreated EGFR-mutant non-small cell lung cancer with
0 Comments
The translation of pediatric discharge instructions is a critical aspect of healthcare, ensuring that patients and their families receive accurate and understandable information regarding follow-up care and medication recommendations. A recent study compared the performance of professional translations, Google Translate, and ChatGPT in translating instructions from English into Spanish, Brazilian Portuguese, and Haitian Creole. The
0 Comments
The recent unanimous support from the FDA advisory committee for the investigational drug donanemab in the treatment of early Alzheimer’s disease has brought new hope to patients with mild cognitive impairment and mild dementia. In an 11-0 vote, the Peripheral and Central Nervous System Drugs Advisory Committee concluded that the benefits of donanemab outweighed its
0 Comments